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Ku autoantigen, a heterodimer of 70- and 80-kDa sub-
units, is a DNA end-binding factor critical for DNA re-
pair. Two domains of p70 mediate DNA binding, one on
the C-terminal and one on the N-terminal portion. The
latter must dimerize with p80 in order to bind DNA,
whereas the former is p80-independent. Both must be
intact for end binding activity in gel shift assays. To
evaluate the role of p80 in DNA binding, deletion mu-
tants were co-expressed with full-length p70 using re-
combinant baculoviruses. We show by several criteria
that amino acids 371–510 of p80 interact with p70. Both
of the p70 dimerization domains bind to the same region
of p80, but apparently to separate sites within that re-
gion. In DNA immunoprecipitation assays, amino acids
179–510 of p80 were required for p80-dependent DNA
binding of p70, whereas in gel shift assays, amino acids
179–732 were necessary. Interestingly, both the p80-de-
pendent and the p80-independent DNA binding sites
preferentially bound to DNA ends, suggesting a model in
which a single Ku heterodimer may juxtapose two bro-
ken DNA ends physically, facilitating their rejoining by
DNA ligases.
Ku antigen was identified and characterized using autoan-
tibodies from the sera of patients with systemic autoimmune
diseases (reviewed in Ref. 1). Later, it was shown to be associ-
ated with a DNA-dependent protein kinase that phosphoryl-
ates chromatin-bound proteins in vitro (2) and is involved in
double-stranded (ds)1 DNA break repair (DSBR), V(D)J recom-
bination, and isotype switching (3–5), as well as telomeric
length maintenance and silencing (6). Ku is a heterodimer of
70-kDa (p70) and ;80-kDa (p80) subunits that binds dsDNA
ends (1, 7). Sequence-specific DNA binding also has been re-
ported (1, 8). Defining the contribution of p70 and p80 to DNA
binding is of interest because of the dual sequence- and end-
specific binding of Ku and because of uncertainty as to its
precise role in DNA repair. In DNA immunoprecipitation and
Southwestern blot assays, p70 binds DNA in the absence of p80
(7, 9, 10), but in gel shift assays, only the dimer can bind (11,
12). Although p80 alone does not bind to DNA, DSBR mutants
in the XRCC5 complementation group have defects in the p80
gene (13–15).
Defining the mechanism of p70-p80 dimerization may help to
explain the role of p80 in sequence-specific DNA binding, DNA
end binding, and/or DSBR. The p70 subunit contains two p80
interaction domains, amino acids 1–115 and 430–482, respec-
tively, as well as two regions involved in DNA binding, each
partially overlapping one of the interaction domains (16). A
p80-independent DNA binding site is located on the C terminus
(amino acids 536–609) (16, 17), whereas the N-terminal region
must bind p80 in order to bind DNA. The goal of this study was
to define the dimerization-dependent DNA binding site. Using
p70 and p80 mutants, a large central domain of p80 involved in
both dimerization and DNA binding was identified. This site,
like the p80-independent DNA binding site, preferentially rec-
ognized DNA ends, suggesting that a single Ku heterodimer
may bind two DNA ends.
EXPERIMENTAL PROCEDURES
Cells and Viruses—K562 (human erythroleukemia) cells were ob-
tained from the American Type Culture Collection (ATCC, Rockville,
MD) and maintained in RPMI 1640 supplemented with 10% fetal bo-
vine serum and penicillin/streptomycin. The Sf9 (Spodoptera frugi-
perda ovary) cell line was obtained from the ATCC, and maintained at
27 °C in Grace’s insect tissue culture medium supplemented with 3.3
g/liter TC yeastolate, 3.3 g/liter lactalbumin hydrolyzate, 10% fetal
bovine serum, and penicillin/streptomycin.
The human p70 and p80 Ku cDNAs were subcloned into a modified
baculovirus transfer vector pVLB4-mp53 and co-transfected with lin-
earized wild-type baculovirus into Sf9 cells as described (16). The re-
combinant baculovirus vectors direct the expression of Ku proteins
fused to an N-terminal polyhistidine sequence and a enterokinase
cleavage site. The recombinant baculoviruses expressing the full-length
p80 or p70 are designated p80-bv and p70-bv respectively.
Recombinant baculoviruses expressing mutant human p80 were con-
structed in the same manner. Truncated p80 cDNAs were amplified by
polymerase chain reaction using primer pairs listed in Table I, and
subcloned into pVLB4-mp53.
Recombinant Protein Expression—Sf9 cells were infected with one or
more recombinant baculoviruses as described (16). Seventy-two hours
after infection, recombinant Ku proteins were identified in cell lysates
by SDS-PAGE and immunoblotting using human autoimmune serum
and/or specific monoclonal antibodies (mAbs).
mAbs—mAbs specific for the human Ku antigen were as described
previously (16). Their isotypes and specificities are as follows: 162,
IgG2a anti-p70/p80 dimer; S10B1, IgG1 anti- p80 (amino acids 179–
371); 111, IgG1 anti-p80 (amino acids 610–705); N3H10, IgG2b anti-
p70 (amino acids 529–541). An IgG2a murine mAb specific for the
polyhistidine tag (HIS-1) was from Sigma.
Immunoblotting and Immunoprecipitation—Immunoblot analysis of
the recombinant p70 and p80 proteins from Sf9 cells or Ku proteins
from K562 cells was performed using murine mAbs (1:1000 dilution)
(16). Radiolabeling of baculovirus-infected Sf9 cells with [35S]methi-
onine/cysteine and immunoprecipitation onto protein A-Sepharose
beads were carried out as described (16). The beads were washed with
1.5 M NaCl NET-Nonidet P-40 buffer (1.5 M NaCl, 50 mM Tris, pH 7.5,
0.3% Nonidet P-40, 2 mM EDTA) and once with NET buffer (0.15 M
NaCl, 50 mM Tris, pH 7.5, 2 mM EDTA). Immunoprecipitated proteins
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were analyzed by SDS-PAGE.
Limited Protease Digestion—Ku heterodimer from K562 cells was
affinity-purified onto mAb 162-coated protein A-Sepharose beads and
digested with proteases (16). Protease V8 (Boehringer Mannheim),
trypsin-treated tosylphenylalanyl chloromethyl ketone (Millipore
Corp., Freehold, NJ), or chymotrypsin (Worthington Biochemical Corp.,
Freehold, NJ) were added to the beads at 2–200 mg/ml in 10 mM
Tris-HCl, pH 7.5, and 2.5 mM CaCl2 for 30 min at 22 °C. The beads were
washed, and p80 fragments remaining associated with the beads were
identified by SDS-PAGE and immunoblotting using S10B1.
Cell Extracts—Sf9 or K562 cells were washed briefly with hypotonic
buffer (10 mM HEPES, pH 7.3, 25 mM KCl, 10 mM NaCl, 1 mM MgCl2,
0.1 mM EDTA), and pellets were resuspended at 2 3 108 cells/ml in the
same buffer supplemented with 0.5 mM dithiothreitol, 1 mM phenyl-
methylsulfonyl fluoride, and aprotinin (0.3 trypsin inhibitor units/ml).
Pellets were lysed by three freeze-thaw cycles and adjusted to 0.5 M KCl
and 10 mM MgCl2. After centrifuging, the supernatant was diluted to
0.1 M KCl and stored at 280 °C.
DNA Binding Assays—A 564-base pair linear double-stranded DNA
fragment from bacteriophage l was radiolabeled with [32P]dATP, and
its binding to affinity-purified Ku antigen was measured by DNA im-
munoprecipitation assay (16). Briefly, cell extract was immunoprecipi-
tated on protein A-Sepharose beads with 3 ml of N3H10, 111, or HIS-1
ascitic fluid. Equal amounts of recombinant Ku proteins were bound to
the beads, as determined by SDS-PAGE with Coomassie Blue staining.
Beads were washed with 1.5 M NaCl NET-Nonidet P-40 buffer, followed
by the same buffer containing 50 mM NaCl. Radiolabeled DNA (25 ng)
was added for 1 h, and the beads were washed again with NET-Nonidet
P-40. Bound DNA was recovered by proteinase K digestion, and an
aliquot of the supernatant was used for scintillation counting.
For gel mobility shift assays, radiolabeled DNA was purified using a
Geneclean III kit (Bio 101, Vista, CA) and then incubated with cell
extracts in 20 ml of binding buffer (10 mM Tris, pH 7.5, 1 mM dithio-
threitol, 5 mM EDTA, 10% glycerol, 150 mM NaCl, 2 mg of closed circular
fX174 Rf I DNA) at 22 °C for 30 min (16). Samples were analyzed by
electrophoresis in a 4% polyacrylamide gel, followed by autoradiogra-
phy. For supershift experiments, purified mAbs (;1 mg) were added to
the binding mixture 5 min after adding probe and incubated for an
additional 30 min at 22 °C before electrophoresis.
RESULTS
Two regions of the p70 interact with p80. Binding of p80 to
one of these interaction domains contributes to the DNA bind-
ing activity of Ku. In the present study, we investigated the
mechanism of p80-p70 dimerization and its role in DNA
binding.
Dimerization Domain of p80—The leucine zipper-like se-
quence of p70 is not required for dimerization with p80 (16).
The role of the leucine zipper-like sequence near the N termi-
nus of p80 (18) in interactions with p70 was investigated by
co-expressing a panel of p80 deletion mutants (Fig. 1A) with
full-length p70 in Sf9 cells using recombinant baculoviruses.
Recombinant protein expression was verified by immunopre-
cipitation using the polyhistidine-specific mAb HIS-1 (Fig. 1, B
and C, HIS). To detect heterodimer formation, the p80 mutants
were co-immunoprecipitated with anti-p70 mAb N3H10 (Fig. 1,
B and C, N3H10). Mutant proteins 179–732, 179–654, 179–
510, 371–654, and 371–510 were co-immunoprecipitated by
N3H10, but 179–400 was not (Fig. 1B), suggesting that an
interaction domain is located in the central portion of p80
(amino acids 371–510), and that the leucine zipper-like region
(amino acids 146–178) is not essential for dimerization with
p70. Even though 179–654 and 179–510 dimerized with p70
less efficiently than 179–732, their interactions were visual-
ized readily by co-immunoprecipitation assay. Since 179–510
interacted with p70, whereas 179–400 did not, amino acids
400–510 may be crucial for dimerization with p70. However,
because 179–400 was expressed less efficiently than the other
constructs, it is difficult to completely exclude the possibility
that some dimerization might occur with this construct.
Mutant 1–178 overlaps the leucine zipper-like sequence, but
was not co-immunoprecipitated by N3H10 (Fig. 1C), indicating
that the leucine zipper-like sequence of p80, like that of p70, is
not required for dimerization. Mutant 400–732 was co-immu-
noprecipitated by N3H10 but not 400–510, 510–654, or 654–
732 (Fig. 1C). Thus, even though amino acids 400–510 are
crucial for p70-p80 dimerization, this region by itself is insuf-
ficient. Additional amino acids either N-terminal (e.g. mutant
371–510) or C-terminal (e.g. mutant 400–732) to the “core”
domain (amino acids 400–510) are necessary for binding to
p70.
Contribution of p80 to Dimerization-specific 162 Epitope—
mAb 162 recognizes an epitope created by dimerization of p70
with p80 and prevents their dissociation in the presence of 1.5
M NaCl and detergent (19). The 162 binding site on p70 (amino
acids 430–542) overlaps the C-terminal interaction domain of
p70 (amino acids 430–482). The relationship of the 162 binding
site to the interaction domain of p80 was investigated (Fig. 2,
A–C). Expression of p70 and p80 deletion mutants was verified
by HIS-1 antibody. mAb 162 immunoprecipitated full-length
p70 when co-expressed with p80 mutant 179–732, but not
371–732, 179–371, or 1–178 (Fig. 2B), suggesting that the
C-terminal half of p80 contributes to formation of the epitope.
mAb 162 also immunoprecipitated p70 when co-expressed with
p80 179–654 or 179–510, but not 179–400 (Fig. 2C), but it did
not immunoprecipitate p70 or any of the p80 deletion mutants
when expressed alone in Sf9 cells (20). These data confirm the
dimerization studies illustrated in Fig. 1B. We conclude that
amino acids 179–510 of p80 contribute to formation of the 162
epitope, and that this region overlaps the dimerization domain
of p80.
To further define the minimal 162 epitope, p70 (amino acids
430–542) (16) was co-expressed with p80 mutants. mAb 162
immunoprecipitated p70 (430–542) when co-expressed with
p80 (179–654 or 179–510), but not p80 (179–400) (data not
shown), indicating that the 162 epitope consists of p70 (430–
542) plus p80 (179–510).
Localization of the Dimerization Site by Limited Proteoly-
TABLE I
Primers used to amplify Ku cDNAs for subcloning into baculovirus transfer vectors
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sis—To confirm the co-immunoprecipitation data, dimerization
of p70 and p80 was studied in the human K562 cell line.
Binding of mAb 162 protects the p70 interaction domain from
proteolysis (16), suggesting that the corresponding region of
p80 may be protected, as well. Ku heterodimer affinity-purified
on mAb 162 was treated with proteases, and p80 fragments
retained on 162 beads after protease treatment were analyzed
by Western blotting using mAb S10B1 (Fig. 3). The smallest
bead-associated p80 fragment after chymotrypsin digestion
was a weak, but consistently visualized, band migrating at ;22
kDa. Western blot analysis using mAb 111 (anti-p80, 610–705)
failed to detect fragments smaller than 60 kDa (data not
shown). Since S10B1 recognizes amino acids 179–371 of p80,
the protease studies support the immunoprecipitation data,
indicating that a dimerization site is located in the central
portion of p80.
Two Domains of p70 Bind Independently to the p80 Dimer-
FIG. 1. Dimerization domain of p80. A, diagram of mutant p80
proteins. Wild-type full-length (1–732) p80 and deletion mutants ex-
pressed in Sf9 cells infected with recombinant baculoviruses are shown.
The amino acid sequences and ability to dimerize with p70 of each
construct are indicated on the right. B and C, co-immunoprecipitation of
p70 and p80 mutants. Sf9 cells co-infected with p70-bv and recombinant
baculoviruses expressing p80 mutants were radiolabeled, and cell ly-
sates immunoprecipitated with anti-polyhistidine mAb (HIS) or anti-
p70 mAb (N3H10) followed by SDS-PAGE and autoradiography. Posi-
tions of p70 and the individual p80 mutants are indicated by arrows.
FIG. 2. mAb 162 binding site. A, diagram of p80 mutants. Full-
length p80 (1–732) and deletion mutants are shown. The amino acid
sequences and recognition by mAb 162 after co-expression and dimer-
ization with wild-type p70 are indicated on the right. B and C, 162
immunoprecipitation. Sf9 cells co-infected with p70-bv and recombi-
nant baculoviruses expressing p80 mutants 179–732, 371–732, 179–
371, or 1–178 (B), or 179–654, 179–510, or 179–400 (C), respectively,
were radiolabeled, and cell lysates immunoprecipitated with anti-poly-
histidine mAb (HIS) or anti-p70/p80 dimer-specific mAb 162, followed
by SDS-PAGE and autoradiography. Positions of p70 and individual
p80 mutants are indicated by arrows.
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ization Site—The p70 protein carries two separate domains
(amino acids 1–115 and 430–482) (16) that apparently interact
with a single domain of p80 (amino acids 371–510). Het-
erodimer assembly was evaluated further by co-expressing p70
deletion mutants overlapping the two dimerization domains
separately or together with p80, and immunoprecipitating with
anti-Ku mAbs (Fig. 4). Protein expression was verified by anti-
polyhistidine immunoprecipitation (Fig. 4, HIS). When co-ex-
pressed individually with p80, p70 (1–433) as well as p70
(430–609) could be co-immunoprecipitated by anti-p80 mAb
111 (Fig. 4, 111). In addition, both 1–433 and 430–609 were
co-immunoprecipitated by mAb 111 when co-expressed to-
gether with p80. The bands intensities were similar regardless
of whether the p70 proteins were co-expressed with p80 sepa-
rately (1–433, 430–609) or together (1–433 1 430–609), sug-
gesting that the p70 mutants do not interfere with each other’s
binding to p80. Anti-p70 mAb N3H10 also co-immunoprecipi-
tated p80 in 430–609/p80 co-expressing lysates. More impor-
tantly, N3H10 co-immunoprecipitated 1–433 along with p80.
Some free 430–609 also was immunoprecipitated, accounting
for the greater intensity of that band (Fig. 4, right panel).
N3H10 does not immunoprecipitate 1–433 when the mutant
protein is expressed alone or co-expressed with 430–609 (data
not shown), indicating that the two p70 dimerization domains
can bind independently to the same p80 molecule. Similar
results were obtained when smaller fragments of p70 and p80
carrying dimerization sites were investigated in the same man-
ner (data not shown). Taken together, these data indicate that
the two dimerization domains of p70 interact with the central
region of p80 and do not compete with one another for binding.
DNA Interaction Domain of p80—The p70 protein has two
DNA binding domains, each partially overlapping one of the
dimerization sites. The C-terminal site (amino acids 536–609)
has DNA end binding activity by itself, whereas N-terminal
DNA binding activity requires dimerization with p80. Partial
activity is exhibited by amino acids 1–115, and complete activ-
ity by amino acids 1–542. Thus, p70 deletion mutants lacking
the p80 independent C-terminal domain, such as 1–600, 1–542,
or 1–115, bind DNA in a p80-dependent manner. To determine
how the p80-dependent site is assembled, the DNA binding
activity of p70 (1–600) co-expressed with a panel of p80 mu-
tants overlapping the dimerization domain of p80 was tested
(Fig. 5). It was necessary to use DNA immunoprecipitation
assays because binding in gel shift assays requires both DNA
binding sites (16). Consistent with previous findings, wild-type
p70 by itself bound to linear dsDNA as well as did the p70/p80
heterodimer (Fig. 5, left). The p70 deletion mutant 1–600
bound DNA poorly, but clearly better than extract from cells
infected with wild-type (WT) baculovirus. However, its activity
was enhanced considerably by dimerization with p80. Partial
p80-dependent DNA binding activity was conferred when p70
(1–600) dimerized with the p80 deletion mutants 179–732,
179–654, or 179–510, each of which overlaps the interaction
domain of p80. Decreased binding of the mutants may relate to
differences in dimerization efficiency. However, comparable
amounts of Ku dimers, determined in preliminary co-immuno-
precipitation experiments using N3H10, were used in each
lane, arguing that the dimers containing truncated p80 con-
structs may bind DNA less well. We conclude that p80 (179–
FIG. 3. Protection of p80 from limited protease treatment by
mAb 162. Ku antigen from K562 cells was affinity-purified onto mAb
162-coated protein A-Sepharose beads, and beads were treated with V8
protease, trypsin, or chymotrypsin (lane 1, 2 mg/ml; lane 2, 20 mg/ml;
lane 3, 200 mg/ml). Afterward, the beads were washed and bound
fragments analyzed by SDS-PAGE and immunoblotting. The nitrocel-
lulose membrane was probed with mAb S10B1 (anti-p80, amino acids
179–371). Protein fragments recognized by S10B1 are indicated by
arrowhead. Positions of molecular size standards are shown on the
right.
FIG. 4. Co-expression p80 with p70 interaction domains. Sf9
cells co-infected with p80-bv and recombinant baculoviruses expressing
the two interaction domains of p70, either separately or together, were
radiolabeled, and cell lysates immunoprecipitated with anti-polyhisti-
dine mAb (HIS), anti-p80 mAb (111), or anti-p70 mAb (N3H10), fol-
lowed by SDS-PAGE and autoradiography. Positions of p80 and the p70
deletion mutants are indicated.
FIG. 5. DNA immunoprecipitation assay. Extract from Sf9 cells
infected with wild-type baculovirus (WT) or recombinant baculoviruses
expressing full-length or mutant p70 were immunoprecipitated with
mAb N3H10. Binding of the affinity-purified proteins to a 564-base pair
32P-labeled bacteriophage l HindIII fragment was tested. Binding of
probe to full-length p70 was tested along with the binding of deletion
mutant (p70.1–600) (open bars). Binding also was evaluated after
dimerizing full-length p80 or deletion mutants 179–732, 179–654, or
179–510 to p70.1–600 (hatched bars). WT, DNA binding activity of cell
lysates from Sf9 cells infected with wild-type baculovirus.
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510) mediates the p80-dependent DNA binding activity of p70.
Role of p80 in Gel Mobility Shift Assay—End binding activity
of Ku in gel shift assays requires both the N- and C-terminal
DNA binding domains of p70 (16). Because p80 is needed for
activity of the N-terminal domain, it also is required for bind-
ing in gel shift assays (11, 12). To establish the region of p80
conferring DNA binding activity in gel shift assays, the DNA
binding of p80 deletion mutants co-expressed with wild-type
p70 was tested. Consistent with previous findings, recombi-
nant Ku heterodimer bound DNA efficiently, whereas p70, p80,
and p80 deletion mutants by themselves failed to bind in the
gel shift assay (Fig. 6 and data not shown). The p80 mutant
179–732, but not 371–732, 179–654, 179–510, or 179–400,
bound DNA after dimerizing with wild-type p70 (Fig. 6). The
multiple bands visible on the gel (Fig. 6, 179–732/p70 lane, B1,
B2, B3) suggest that dimerization also restores the internal
translocation property of Ku (21). Binding of the recombinant
protein 179–732/p70 to DNA was verified by supershift assays
using anti-Ku mAb 162 and anti-polyhistidine mAb HIS-1
(data not shown). Paradoxically, we have shown previously
that dimerization with wild-type p80 compensates partially for
the deletion of a portion (amino acids 601–609) of the p70
C-terminal DNA binding domain (p70 (1–600), p70D), even
though the intact C-terminal domain binds DNA independ-
ently of p80 (16). However, p80 (179–732) failed to restore the
DNA binding activity of p70D (Fig. 6, 179–732/p70D lane).
Thus, p80 (179–732) was required for Ku DNA end binding
activity in the gel shift assay, but this region was insufficient to
restore the DNA binding activity of p70D. Only full-length p80
exhibited the latter effect.
Role of p80 in DNA End Binding—The C-terminal DNA
binding domain of p70 recognizes dsDNA termini preferen-
tially (17), and could, by itself, explain the end binding activity
of Ku antigen. The role of the p80-dependent DNA binding site
has not been defined. To evaluate whether this site also exhib-
its preferential end binding activity, competition experiments
were carried out as detailed in Ref. 17. Consistent with previ-
ous findings, binding of the intact p70/p80 heterodimer to a
linear double-stranded DNA probe was preferentially inhibited
by linear dsDNA (Fig. 7). There was little inhibition of binding
by closed circular DNA (fX174 Rf I DNA or pBKS plasmid
DNA) or by tRNA. The full-length p70 protein by itself and p70
(amino acids 430–609) displayed a similar inhibition pattern,
suggesting that p70 also binds preferentially to DNA termini.
Dimerization of each of the p70 DNA binding domains
(p70.430–609 and p70.1–542, respectively) with full-length
p80 resulted in constructs that also bound preferentially to
linear dsDNA. Binding was not inhibited significantly by
fX174 Rf I DNA, pBKS plasmid DNA, or tRNA.
DISCUSSION
Deficiency of Ku autoantigen leads to defective DSBR and
V(D)J recombination, resulting in x-ray sensitivity and severe
combined immunodeficiency (22). Despite the fact that the p70
Ku subunit can bind dsDNA ends independently of p80 (17),
DSBR is absent in cells with p80 mutations (13, 14), apparently
due to the existence of a second, dimerization-dependent, DNA
binding site (16). In the present study, amino acids 371–510 of
p80 was shown to mediate dimerization with p70 and recogni-
tion by the Ku dimer-specific mAb 162, in addition to partici-
pating in DNA binding. As illustrated in Fig. 8, the locations of
the DNA binding and dimerization domains of p80 are consist-
ent with the DSBR-deficient phenotypes of the XR-V9B and
XR-V15B cell lines (13). These data also are consistent with the
recent finding that heterodimer formation is essential for
DSBR in vivo (15).
Assembly of Ku Heterodimer—Amino acids 371–510 of p80
were shown to mediate dimerization with p70 (Fig. 1). A “core”
domain (amino acids 400–510), along with sequences flanking
this region, may play a crucial role in dimerization, because
p80 mutants 179–510, 371–510, and 400–732, but not 400–
510, can interact with p70. The leucine zipper-like motif near
the N terminus of p80 (amino acids 146–178; Fig. 8) (18) is
outside of the dimerization domain, consistent with previous
observations that it is dispensable for interactions with p70 in
the yeast two-hybrid system (12, 23). Similarly, the leucine
zipper-like motif of p70 does not mediate dimerization with p80
(16). Although the catalytic subunit of DNA-dependent protein
kinase contains an extensive leucine zipper-like motif (24), it is
outside the domain that interacts with Ku (25). The leucine
zipper-like sequences may interact with other proteins or may
not be of functional significance.
The location of the p80 dimerization site reported here is
consistent with recent observations of others (23), but less so
with other reports (12, 26). Although the region identified here
contains the 28-amino acid “minimal functional interaction
domain” reported previously (26), the present data indicate
that additional sequences are important, either for protein-
protein interactions or for promoting folding of the dimeriza-
tion site. The interaction sequence defined here apparently is
distinct from the C-terminal 32-kDa region reported to be im-
portant for subunit-subunit interaction in the yeast two-hybrid
system (12). The explanation for this discrepancy is unclear.
Three lines of evidence support the idea that the central,
rather than C-terminal, portion of p80 interacts with p70. 1)
This region is co-immunoprecipitated along with wild-type p70
(Fig. 1); 2) the same region is required for recognition by mAb
162 (Fig. 2), which is specific for the p70/p80 dimer and stabi-
lizes it under dissociating conditions (19); and 3) mAb 162 also
protects this region from limited proteolysis (Fig. 3). Together
with previous data (16), these data indicate that the conforma-
tional epitope recognized by mAb 162 comprises amino acids
430–542 of p70 in association with amino acids 179–510 of p80
(Fig. 8).
An unexpected finding was that the two p70 dimerization
domains, amino acids 430–542 and 1–433, respectively, asso-
ciate with the same region of p80. Moreover, both domains can
associate with the same p80 molecule (Fig. 4). The two p70
FIG. 6. DNA binding by gel mobility shift assay. The same radio-
labeled linear DNA probe used for the DNA immunoprecipitation assay
(Fig. 6) was incubated with extracts from Sf9 cells infected or co-
infected with full-length p70 or p70.1–600 mutant (amino acids 1–600,
p70D) and full-length or mutant p80. Extracts from human K562 cells
also was tested as well as free probe without any cell extract (lane P).
Binding mixtures were resolved by electrophoresis on a 4% polyacryl-
amide gel, followed by autoradiography. The positions of free probe (FP)
and complexes formed with extracts from K562 cells and infected Sf9
cells (B1–B3) are indicated.
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domains may associate with separate sites in the central inter-
action domain of p80 because the two p70 interaction domains
did not appear to compete with one another for binding (see
Fig. 4, N3H10 immunoprecipitates). Although the precise loca-
tion of the two p80 subdomains remains to be determined, the
conformational integrity of the core domain (amino acids 400–
510) is crucial for binding to p70 because additional amino
acids facilitate dimerization and the core domain did not dimer-
ize with p70 by itself (Fig. 1). Recent data indicating that
mutations at positions 453 and 454 abrogate the interaction of
p80 with p70 (26) are consistent with these observations.
p80-dependent DNA Binding Site of Ku—The interactions of
Ku with DNA are complex. End binding activity of Ku is of
critical importance for DSBR and V(D)J recombination (15, 22).
In addition, internal, sequence-specific binding to a negative
regulatory element in the long terminal repeat of mouse mam-
mary tumor virus has been reported (8) as well as interactions
with single-stranded DNA or other substrates (21). Thus, like
many other DNA binding factors, Ku antigen may be multi-
functional (27).
At least two different sites interact with DNA (Fig. 9). A
p80-independent site is located on the C-terminal end of p70
and binds preferentially to dsDNA ends (16, 17). The N-termi-
nal portion of p70 forms a second site upon dimerization with
p80. Neither site by itself is sufficient for DNA binding activity
in gel mobility shift assays, but together they confer activity
(16). A region overlapping the minimal dimerization domain of
p80 confers p80-dependent DNA binding activity (Fig. 5). In-
terestingly, a much larger portion of p80, including the intact C
terminus (amino acids 179–732), probably is needed for DNA
binding in gel mobility shift assays (Fig. 6). This site, like the
p80-independent site, binds preferentially to dsDNA ends
(Fig. 7).
Models for the Interaction of Ku with DNA—The existence of
two DNA end binding sites may have implications for the
function of Ku. Although it is clear that Ku is an integral factor
in DSBR, its precise role remains uncertain. Two models have
been proposed: 1) that Ku protects DNA ends from exonucleo-
lytic degradation, and 2) that it plays an active role in the
rejoining process. The first possibility is suggested by the fact
that imprecise joining occurs at higher frequency in cells with
mutant Ku (28, 29). However, the direct role of Ku antigen in
non-homologous, and not homologous, recombination (30)
strongly supports the second model. In addition, it recently has
been shown that Ku increases the frequency of accurate end
joining mainly by increasing the ligation rate, not by protecting
ends from degradation (31). Moreover, p80 is not required for
the protection of DNA ends during V(D)J recombination in
Ku80 knockout mice (32). Thus, the available evidence favors
the idea that Ku antigen physically juxtaposes broken DNA
ends, enhancing the activity of eukaryotic DNA ligases (31).
This model also is consistent with atomic force microscopy data
indicating that Ku can join together two DNA ends (33–35). It
has been proposed that, upon interacting with two DNA ter-
mini, tetramerization of Ku may facilitate their juxtaposition
(33). Our data suggest an alternative model: that a single Ku
heterodimer might link two DNA ends, helping to ensure that
they are aligned properly for ligation (Fig. 9). This model is
supported by the atomic force microscopy studies, suggesting
FIG. 7. Binding preferences of the
two Ku DNA-binding sites. Extracts
from Sf9 cells infected or co-infected with
recombinant baculoviruses expressing
full-length or mutant p70 or p80 were im-
munoprecipitated with mAbs N3H10 or
111. Binding of the affinity-purified pro-
teins to a 564-base pair, 32P-labeled bac-
teriophage l HindIII fragment was tested
in the presence of 0, 50, or 500 ng of cold
competitor (sonicated salmon sperm DNA
(linear dsDNA), fX174 (RFI) DNA (closed
circular dsDNA), pBKS plasmid DNA
(closed circular dsDNA), or yeast tRNA,
respectively). Radioactivity remaining on
the beads was quantitated by scintillation
counting and plotted as percentage of
DNA bound without competitor.
FIG. 8. Functional domains of p80. At the top is a diagram of the
full-length wild-type p80 protein showing the location of a leucine
zipper-like sequence (amino acids 146–178) previously identified. In-
ternal deletions reported previously (13) in the radiation-sensitive ham-
ster mutant cell lines XR-V9B (D267–350) and XR-V15B (D372–417)
are diagrammed. The dimerization site identified in Fig. 1 (amino acids
371–510) is indicated by solid shading, and regions involved in DNA
binding activity as indicated by immunoprecipitation (amino acids 179–
510) or gel shift (amino acids 179–732) assays are diagonally cross-
hatched. A region involved along with p70 (amino acids 430–542) in
formation of the 162 epitope (p80 amino acids 179–510) is shown at the
bottom.
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that the size of the Ku protein is consistent with the presence
of a single Ku heterodimer at each DNA junction (35). Never-
theless, further studies are needed to verify that Ku joins DNA
fragments as a dimer, instead of a tetramer. We cannot exclude
the possibility that two binding sites are needed in order for Ku
to properly contact a single DNA end. For instance, it is possi-
ble that the first site binds DNA and then slides along it,
whereas the second site allows Ku to pause at the DNA end. A
similar two-site model may explain the binding of p53 to single-
stranded DNA ends and internal segments (36). The two sites
also could confer the ability to bind different DNA or RNA
substrates (8, 37), although so far we have not obtained evi-
dence for this possibility in competition studies similar to those
in Fig. 7.
Molecular Basis of Ku Mutations—The present data may be
relevant to the phenotypes of mutant hamster cell lines in the
x-ray cross-complementing (XRCC) 5 group. Two XRCC5 group
mutant cell lines, XR-V15B and XR-V9B, are deficient in both
DSBR and V(D)J recombination (13). They have internal in-
frame deletions of 84 and 46 amino acids, respectively (13),
resulting in the deletion of amino acids 267–350 (XR-V9B) and
372–417 (XR-V15B) of p80 (Fig. 8). In view of the locations of
the p70 interaction domain (amino acids 371–510) and a region
involved in p80-dependent DNA binding (amino acids 179–
510), XR-V9B may be deficient in DSBR because of an inability
to form the p80-dependent DNA binding site. Dimerization
should occur normally. In contrast, our data predict that p80
mutant XR-V15B may be inactive in DSBR because it cannot
dimerize with p70 (Fig. 8).
The p80 mutants described by Singleton et al. (14) also are of
interest with respect to the dimerization and DNA binding
domains reported here. Deletion mutants lacking the N-termi-
nal 40, 69, or 114 amino acids of p80 had undetectable DNA end
binding activity and were radiosensitive. However, the present
data suggest that p70 dimerization and DNA binding activity
(both by immunoprecipitation and gel shift assays) of these
mutants should be intact. Interestingly, although the three
mutants had wild-type or reduced levels of p80 protein, all had
low levels of p70 compared with wild-type cells (14). Dimeriza-
tion with p70 prevents the rapid degradation of p80 in K562
cells (38). In other cell lines, dimerization stabilizes both pro-
teins (1, 13). The low levels of p70 in N-terminally truncated
p80 mutants (14) raise the possibility that sequences located
near the N terminus may play a role in the mutual stabilization
of p70 and p80 in certain cell lines, even though this region is
dispensable for dimerization. Thus, it is conceivable that the
radiosensitivity of the mutants described by Singleton et al.
reflects enhanced degradation of Ku rather than lack of func-
tion (dimerization or DNA binding). Additional studies are
needed to examine whether sequences located outside the min-
imal dimerization domain play a role in protecting the het-
erodimer from degradation.
In summary, we have defined regions of p80 mediating
dimerization with p70 as well as p80-dependent DNA binding
activity. The functional domains identified here may help to
explain the phenotypes of radiosensitive XRCC5 mutants.
More importantly, the two DNA binding domains both bind
dsDNA ends preferentially, consistent with the idea that Ku
antigen acts by physically apposing two broken DNA ends,
facilitating their ligation during DSBR (30, 31, 33, 35).
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FIG. 9. Model of the structure of Ku antigen. A central p80
dimerization domain p80 interacts with two dimerization sites near the
C- and N termini of p70, respectively. Interaction of p80 with the
N-terminal dimerization site of p70 promotes the formation of a p80-
dependent DNA binding site. A second DNA binding site in the C-
terminal portion of p70 is p80-independent. Both sites bind preferen-
tially to DNA ends, suggesting that a single molecule of Ku may
juxtapose two DNA termini, facilitating their ligation by other compo-
nents of the DNA repair apparatus.
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